# Shattuck (STTK) — News

STTK · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sttk/news

## Recent headlines

- [Shattuck Labs Inc: Needham raises target price to $19 from $17](https://www.ainvest.com/news/shattuck-labs-needham-raises-target-price-19-17-2610) — AInvest Wire, Oct 2, 2026
  Shattuck Labs Inc. (STTK) has seen recent analyst activity, with Needham raising its price target for the stock to $19 from $17, reflecting a positive outlook on the company’s development pipeline and clinical progress. The move aligns with broader analyst sentiment, as eight analysts currently…
- [Shattuck Labs - Existing cash expected to fund operations into 2029](https://www.ainvest.com/news/shattuck-labs-existing-cash-expected-fund-operations-2029-2610) — AInvest Wire, Oct 1, 2026
- [Shattuck Labs - Ind submission for phase 2 trial expected in October 2026](https://www.ainvest.com/news/shattuck-labs-ind-submission-phase-2-trial-expected-october-2026-2610) — AInvest Wire, Oct 1, 2026
- [Shattuck Labs - Phase 2 trial to start in 2026; 16-week data expected in H1 2028](https://www.ainvest.com/news/shattuck-labs-phase-2-trial-start-2026-16-week-data-expected-h1-2028-2610) — AInvest Wire, Oct 1, 2026
  Shattuck Labs, Inc. (STTK) has announced plans to initiate a Phase 2 clinical trial in 2026, marking a key milestone in the development of its drug candidate, DR3. The trial is part of the company’s broader strategy to advance its pipeline and generate data to support future regulatory submissions.…
- [Shattuck Labs - To initiate phase 2 trial of SL-325 in hidradenitis suppurativa](https://www.ainvest.com/news/shattuck-labs-initiate-phase-2-trial-sl-325-hidradenitis-suppurativa-2610) — AInvest Wire, Oct 1, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).